Clinical trial
Mechanisms of Weight Loss With SGLT2 Inhibition
NCT02360774 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of Weight Loss With SGLT2 Inhibition
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- August 31, 2018
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity, overweight, type 2 diabetes